Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

Direct comparative studies of atorvastatin (Lipitor; Pfizer, Inc., New York, NY) vs. older available statins suggest that it is better at helping patients achieve National Cholesterol Education ...